These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36015223)

  • 21. mRNA-Based Vaccines Are Highly Immunogenic and Confer Protection in the Gnotobiotic Pig Model of Human Rotavirus Diarrhea.
    Hensley C; Roier S; Zhou P; Schnur S; Nyblade C; Parreno V; Frazier A; Frazier M; Kiley K; O'Brien S; Liang Y; Mayer BT; Wu R; Mahoney C; McNeal MM; Petsch B; Rauch S; Yuan L
    Vaccines (Basel); 2024 Mar; 12(3):. PubMed ID: 38543894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of trivalent non-replicating rotavirus vaccine antigens in the presence of aluminum adjuvant.
    McAdams D; Lakatos K; Estrada M; Chen D; Plikaytis B; Sitrin R; White JA
    J Immunol Methods; 2021 Jul; 494():113056. PubMed ID: 33857473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses.
    Luo G; Zeng Y; Yang H; Li Y; Yang L; Li C; Song F; Zhang S; Li T; Ge S; Zhang J; Xia N
    iScience; 2022 Oct; 25(10):105099. PubMed ID: 36185383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal immunization of pregnant cattle with recombinant VP8* protein of bovine rotavirus elicits neutralizing antibodies to multiple serotypes. Colostral neutralizing antibody by rotavirus VP8*.
    Yoo D; Lee J; Harland R; Gibbons E; Elazhary Y; Babiuk LA
    Adv Exp Med Biol; 1997; 412():405-11. PubMed ID: 9192047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity and protective efficacy of rotavirus VP8* fused to cholera toxin B subunit in a mouse model.
    Xue M; Yu L; Jia L; Li Y; Zeng Y; Li T; Ge S; Xia N
    Hum Vaccin Immunother; 2016 Nov; 12(11):2959-2968. PubMed ID: 27435429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological response to recombinant VP8* subunit protein of bovine roravirus in pregnant cattle.
    Lee J; Babiuk LA; Harland R; Gibbons E; Elazhary Y; Yoo D
    J Gen Virol; 1995 Oct; 76 ( Pt 10)():2477-83. PubMed ID: 7595351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a bivalent recombinant vaccine candidate targeting norovirus and rotavirus: Antibodies to rotavirus NSP4 exert antidiarrheal effects without virus neutralization.
    Cao H; Wu J; Luan N; Wang Y; Lin K; Liu C
    J Med Virol; 2022 Aug; 94(8):3847-3856. PubMed ID: 35474320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Norovirus P particle, a novel platform for vaccine development and antibody production.
    Tan M; Huang P; Xia M; Fang PA; Zhong W; McNeal M; Wei C; Jiang W; Jiang X
    J Virol; 2011 Jan; 85(2):753-64. PubMed ID: 21068235
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization and immunogenicity of a novel chimeric hepatitis B core-virus like particles (cVLPs) carrying rotavirus VP8*protein in mice model.
    Latifi T; Jalilvand S; Golsaz-Shirazi F; Arashkia A; Kachooei A; Afchangi A; Zafarian S; Roohvand F; Shoja Z
    Virology; 2023 Nov; 588():109903. PubMed ID: 37832344
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual Recognition of Sialic Acid and αGal Epitopes by the VP8* Domains of the Bovine Rotavirus G6P[5] WC3 and of Its Mono-reassortant G4P[5] RotaTeq Vaccine Strains.
    Alfajaro MM; Kim JY; Barbé L; Cho EH; Park JG; Soliman M; Baek YB; Kang MI; Kim SH; Kim GJ; Park SI; Pendu JL; Cho KO
    J Virol; 2019 Sep; 93(18):. PubMed ID: 31243129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
    Li Y; Xue M; Yu L; Luo G; Yang H; Jia L; Zeng Y; Li T; Ge S; Xia N
    Vaccine; 2018 Apr; 36(16):2086-2092. PubMed ID: 29555220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of porcine P[6], P[7]-specific △VP8* rotavirus subunit vaccines with a tetanus toxoid universal T cell epitope.
    Wen X; Wei X; Ran X; Ni H; Cao S; Zhang Y
    Vaccine; 2015 Aug; 33(36):4533-9. PubMed ID: 26192360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma VP8∗-Binding Antibodies in Rotavirus Infection and Oral Vaccination in Young Bangladeshi Children.
    Lee B; Colgate ER; Carmolli M; Dickson DM; Gullickson S; Diehl SA; Ara R; Alam M; Kibria G; Abdul Kader M; Afreen S; Ferdous T; Haque R; Kirkpatrick BD
    J Pediatric Infect Dis Soc; 2022 Apr; 11(4):127-133. PubMed ID: 34904667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine.
    Lakatos K; McAdams D; White JA; Chen D
    Hum Vaccin Immunother; 2020 Aug; 16(8):1957-1968. PubMed ID: 31995444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice.
    Tamminen K; Lappalainen S; Huhti L; Vesikari T; Blazevic V
    PLoS One; 2013; 8(7):e70409. PubMed ID: 23922988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relative roles of GM1 ganglioside, N-acylneuraminic acids, and α2β1 integrin in mediating rotavirus infection.
    Fleming FE; Böhm R; Dang VT; Holloway G; Haselhorst T; Madge PD; Deveryshetty J; Yu X; Blanchard H; von Itzstein M; Coulson BS
    J Virol; 2014 Apr; 88(8):4558-71. PubMed ID: 24501414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The αTSR Domain of
    Xia M; Vago F; Han L; Huang P; Nguyen L; Boons GJ; Klassen JS; Jiang W; Tan M
    Int J Nanomedicine; 2023; 18():3087-3107. PubMed ID: 37312932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant Subunit Rotavirus Trivalent Vaccine Candidate: Physicochemical Comparisons and Stability Evaluations of Three Protein Antigens.
    Agarwal S; Hickey JM; Sahni N; Toth RT; Robertson GA; Sitrin R; Cryz S; Joshi SB; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):380-393. PubMed ID: 31400347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic diversity of G1P[8] rotavirus VP7 and VP8* antigens in Finland over a 20-year period: No evidence for selection pressure by universal mass vaccination with RotaTeq® vaccine.
    Hemming M; Vesikari T
    Infect Genet Evol; 2013 Oct; 19():51-8. PubMed ID: 23831933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycan binding patterns of human rotavirus P[10] VP8* protein.
    Pang LL; Wang MX; Sun XM; Yuan Y; Qing Y; Xin Y; Zhang JY; Li DD; Duan ZJ
    Virol J; 2018 Oct; 15(1):161. PubMed ID: 30340611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.